Neonatal administration of isoflavones attenuates deterioration of bone tissue in female but not male mice

Journal of Nutrition

Volumn 140, Issue 4, 2010, Pages 766-772

  Kaludjerovic, Jovana ^a   Ward, Wendy E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORN OIL; DAIDZEIN; DIETHYLSTILBESTROL; GENISTEIN; ISOFLAVONE DERIVATIVE; SEX HORMONE; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; FEMALE; FEMUR; LUMBAR SPINE; LUMBAR VERTEBRA; MALE; MOUSE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; SEX DIFFERENCE; TRABECULAR BONE;

ANIMALS; BODY WEIGHT; BONE DENSITY; DIETHYLSTILBESTROL; DRUG COMBINATIONS; FEMALE; FEMUR NECK; GENISTEIN; INJECTIONS, SUBCUTANEOUS; ISOFLAVONES; LUMBAR VERTEBRAE; MALE; MICE; ORCHIECTOMY; OSTEOPOROSIS; OVARIECTOMY; RANDOM ALLOCATION; SOYBEAN PROTEINS;

MUS; ZEA MAYS;

EID: 77949710225     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.116343     Document Type: Article

References (53)

1. Piekarz AV, Ward WE. Effect of neonatal exposure to genistein on bone metabolism in mice at adulthood. Pediatr Res. 2007;61:48-53.
2. Kaludjerovic J, Ward WE. Neonatal exposure to daidzein, genistein, or the combination modulates bone development in female CD-1 mice. J Nutr. 2009;139:467-73.
3. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab. 1998;83:2223-35.
4. Greendale GA, FitzGerald G, Huang M-H, Sternfeld B, Gold E, Seeman T, Sherman S, Sowers M. Dietary soy isoflavones and bone mineral density: results from the study of women's health across the nation. Am J Epidemiol. 2002;155:746-54.
5. Cooper C, Campion G, Melton L Jr. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285-9.
6. Lau EM, Cooper C. The epidemiology of osteoporosis. The oriental perspective in a world context. Clin Orthop Relat Res. 1996;65-74.
7. Lauderdale DS, Jacobsen SJ, Furner SE, Levy PS, Brody JA, Goldberg J. Hip fracture incidence among elderly asian-american populations. Am J Epidemiol. 1997;146:502-9.
8. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med. 1997;29:95-120.
9. USDA. Iowa State University database on the isoflavoen contenet of food. 1999 [cited 2009 Sept 14]. Available from: www.nal.usda.gov/fnic/foodcomp/Data/ isoflav/isfl-tbl.pdf.
10. Cederroth CR, Nef S. Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol. 2009;304:30-42.
11. Mei J, Yeung SSC, Kung AWC. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab. 2001;86:5217-21.
12. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr. 2000;72:844-52.
13. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998;68:S1375-9.
14. Lydeking-Olsen E, Beck-Jensen JE, Setchell KD, Holm-Jensen T. Soymilk or progesterone for prevention of bone loss - a 2 year randomized, placebo-controlled trial. Eur J Nutr. 2004;43:246-57.
15. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res. 2002;17:1904-12.
16. Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EHF, Aleman A, Lampe JW, van der Schouw YT. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA. 2004;292:65-74.
17. Gallagher JC, Satpathy R, Rafferty K, Haynatzka V. The effect of soy protein isolate on bone metabolism. Menopause. 2004;11:290-8.
18. Roughead ZK, Hunt JR, Johnson LK, Badger TM, Lykken GI. Controlled substitution of soy protein for meat protein: effects on calcium retention, bone, and cardiovascular health indices in postmenopausal women. J Clin Endocrinol Metab. 2005;90:181-9.
19. Cheong JM, Martin BR, Jackson GS, Elmore D, McCabe GP, Nolan JR, Barnes S, Peacock M, Weaver CM. Soy isoflavones do not affect bone resorption in postmenopausal women: a dose-response study using a novel approach with 41Ca. J Clin Endocrinol Metab. 2007;92:577-82.
20. Brink E, Coxam V, Robins S, Wahala K, Cassidy A, Branca F. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr. 2008;87:761-70.
21. Soder O. Perinatal imprinting by estrogen and adult prostate disease. Proc Natl Acad Sci USA. 2005;102:1269-70.
22. United Nation Standing Committee on Nutrition. Double burden of malnutrition: a common agenda. 33rd Annual Session of the Standing Committee on Nutrition Geneva: United Nations; 2006.
23. Lucas A. Long-term programming effects of early nutrition: implications for the preterm infant. J Perinatol. 2005;25 Suppl 2:S2-6.
24. WHO and FAO. Diet, nutrition and the prevention of chronic disease Geneva: WHO; 2003.
25. Hill LW, Stuart HC. A soy bean food preparation for feeding infants with milk idiosyncrasy. JAMA. 1929;93:985-7.
26. American Academy of Pediatrics Committee on Nutrition. Soy protein-based formulas: recommendations for use in infant feeding. Pediatrics. 1998;101:148-53.
27. Berger-Achituv S, Shohat T, Romano-Zelekha O, Ophir E, Rachmani S, Malovizky D, Garty BZ. Widespread use of soy-based formula without clinical indications. J Pediatr Gastroenterol Nutr. 2005;41:660-6.
28. Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, Puntis J, Rieu D, Rigo J, Shamir R, et al. Soy protein infant formulae and follow-on formulae: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2006;42:352-61.
29. Ward WE, Piekarz AV. Effect of prenatal exposure to isoflavones on bone metabolism in mice at adulthood. Pediatr Res. 2007;61:438-43.
30. Ward WE, Piekarz AV, Fonseca D. Bone mass, bone strength, and their relationship in developing CD-1 mice. Can J Physiol Pharmacol. 2007;85:274-9.
31. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr. 1997;127 Suppl 5:S838-41.
32. Corbier P, Edwards DA, Roffi J. The neonatal testosterone surge: a comparative study. Arch Int Physiol Biochim Biophys. 1992;100:127-31.
33. Winter JS, Faiman C, Hobson WC, Prasad AV, Reyes FI. Pituitary-gonadal relations in infancy. I. Patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee. J Clin Endocrinol Metab. 1975;40:545-51.
34. Migliaccio S, Newbold RR, Teti A, Jefferson WJ, Toverud SU, Taranta A, Bullock BC, Suggs CA, Spera G, et al. Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood. Bone. 2000;27:47-52.
35. Canadian Council on Animal Care. Guide to the care and use of experimental animals. Ottawa; 1993:1-212.
36. Fonseca D, Ward WE. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone. 2004;35:489-97.
37. Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 2002;298:843-6.
38. Chen JR, Lazarenko OP, Blackburn ML, Badeaux JV, Badger TM, Ronis MJ. Infant formula promotes bone growth in neonatal piglets by enhancing osteoblastogenesis through bone morphogenic protein signaling. J Nutr. 2009;139:1839-47.
39. Kimmel D. Animal models in osteoporosis research. 2nd ed. New York: Academic Press; 2002.
40. Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN. Developmental exposure to estrogenic compounds and obesity. Birth Defects Res A Clin Mol Teratol. 2005;73:478-80.
41. Mardon J, Mathey J, Kati-Coulibaly S, Puel C, Davicco MJ, Lebecque P, Horcajada MN, Coxam V. Influence of lifelong soy isoflavones consumption on bone mass in the rat. Exp Biol Med (Maywood). 2008;233:229-37.
42. Levy JR, Faber KA, Ayyash L, Hughes CL Jr. The effect of prenatal exposure to the phytoestrogen genistein on sexual differentiation in rats. Proc Soc Exp Bio Med. 1995;208:60-6.
43. Dang Z, Lowik CW. The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J Bone Miner Res. 2004;19:853-61.
44. Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB, Helferich WG, Cooke PS. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology. 2003;144:3315-20.
45. Kim H-K, Nelson-Dooley C, Della-Fera MA, Yang J-Y, Zhang W, Duan J, Hartzell DL, Hamrick MW, Baile CA. Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr. 2006;136:409-14.
46. Penza M, Montani C, Romani A, Vignolini P, Pampaloni B, Tanini A, Brandi ML, Alonso-Magdalena P, Nadal A, et al. Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology. 2006;147:5740-51.
47. Ronis MJ, Chen Y, Badeaux J, Badger TM. Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J Nutr. 2009;139:1431-8.
48. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA. 2000;97:12729-34.
49. Stroescu V, Dragan J, Simionescu L, Stroescu OV. Hormonal and metabolic response in elite female gymnasts undergoing strenuous training and supplementation with SUPRO Brand isolated soy protein. J Sports Med Phys Fitness. 2001;41:89-94.
50. Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavone intake and body composition in postmenopausal women. Menopause. 2003;10:427-32.
51. Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, Allegro G, Kaaks R. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev. 2001;10:25-33.
52. Kaludjerovic J, Ward WE. Diethylstilbesterol has gender-specific effects on weight gain and bone development in mice. J Toxicol Environ Health A. 2008;71:1032-42.
53. Faber KA, Hughes CL Jr. The effect of neonatal exposure to diethyl-stilbestrol, genistein, and zearalenone on pituitary responsiveness and sexually dimorphic nucleus volume in the castrated adult rat. Biol Reprod. 1991;45:649-53.